PAL
Click for more information
0.00% 29.5¢ palla pharma limited

matters arising from review. Not a good sign.

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. XLKL
    101 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    15/12/21
    09:06
    Post #: 58299422
    matters arising from review. Not a good sign.
    PAL Price at posting: 29.5¢ Sentiment: Hold Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS New insights revealed: high-grade lode gold/copper deposit model for El Dovio Project reinterpreted—see the potential
right-arrow Created with Sketch.
NEWS Revised model reveals high-grade gold/copper potential at El Dovio—find out what’s been uncovered
right-arrow Created with Sketch.
NEWS New gold-copper assays boost confidence in major porphyry target—discover the potential
right-arrow Created with Sketch.
NEWS $140,000 in grant funding has been secured for drilling at Golden Ridge, with preparations underway for two exciting prospects
right-arrow Created with Sketch.
NEWS High-grade manganese found at the W2 prospect in Wandanya
right-arrow Created with Sketch.
EBR FDA commences substantive review of EBR’s PMA application
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.